CENTRAL GARDEN & PET CO
Company snapshot
A consistent view of the latest supported company value and reported operating results.
Fundamental lens
Four transparent questions from retained financial evidence. Each result stands on its own; Grizzly Bulls does not combine them into a score, ranking, or recommendation.
Trailing-twelve-month net income is positive. As of 2026-06-27.
Trailing-twelve-month operating cash flow less capital expenditures is positive. As of 2026-06-27.
Reported current assets exceed reported current liabilities on the latest comparable retained balance sheet. As of 2026-06-27.
Comparable retained change history is not available through this reader.
How this lens works
Profitability uses only the sign of retained trailing-twelve-month net income. Cash generation uses only the sign of retained trailing-twelve-month free cash flow, defined as operating cash flow less capital expenditures.
Liquidity compares current assets with current liabilities only when both are retained for the same reporting date. It does not infer liquidity from differently dated balance sheets.
Recent operating direction uses the latest supported material financial event when comparable history exists. The existing change methodology requires at least a 10% absolute change or a sign/zero transition and compares quarterly results only with the same fiscal quarter year over year.
Market summary
Completed-session reference prices from IEX for Oct 16, 2026.
Price statistics
IEX historical data reflects IEX activity only and is presented as a source-scoped reference point, not as consolidated U.S. market history. Prices are unadjusted. Price returns exclude dividends and are not total returns. Historical statistics appear only when the retained source-session chain is complete and no split-like share-basis discontinuity is detected for that calculation window.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Price history
Recent completed-session closing-price history for this listing. The chart shows raw, unadjusted single-exchange reference observations rather than a consolidated U.S. market close.
Derived reference metrics are omitted for this listing because the required history-quality checks did not clear for the full retained window.
About this market data
IEX historical data reflects IEX activity only and is presented as a source-scoped reference point, not as consolidated U.S. market history.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
The raw chart can show a discontinuity around a stock split because it is intentionally unadjusted. The screened metrics use only explicitly registered positive split events and do not assert complete split history.
Listing & sources
Ticker: CENT · Exchange: Nasdaq · Common Stock
SEC issuer CIK: 0000887733
Listing source refreshed: 2026-09-13
Financials
SEC-reported financial statement history with filing dates preserved. Annual view retains up to four fiscal years; quarterly view retains up to five fiscal quarters. Missing cells mean a supported fact is unknown and are not treated as zero.
Income statement
| Metric | TTM · 2026-06-27 | FY 2025 · 2025-09-27 | FY 2025 · 2024-09-28 | 2023-09-30 | 2022-09-24 |
|---|---|---|---|---|---|
| Revenue | $3.08B Filed 2026-08-06 | $3.13B Filed 2025-11-26 | $3.2B Filed 2025-11-26 | $3.31B Filed 2025-11-26 | $3.34B Filed 2024-11-27 |
| Cost of revenue | $2.08B Filed 2026-08-06 | $2.13B Filed 2025-11-26 | $2.26B Filed 2025-11-26 | $2.36B Filed 2025-11-26 | $2.35B Filed 2024-11-27 |
| Gross profit | $1B Filed 2026-08-06 | $997.34M Filed 2025-11-26 | $943.74M Filed 2025-11-26 | $946.84M Filed 2025-11-26 | $992.31M Filed 2024-11-27 |
| Operating income | $249.91M Filed 2026-08-06 | $250.04M Filed 2025-11-26 | $185.39M Filed 2025-11-26 | $210.65M Filed 2025-11-26 | $260.04M Filed 2024-11-27 |
| Pretax income | $219.18M Filed 2026-08-06 | $216.75M Filed 2025-11-26 | $142.43M Filed 2025-11-26 | $162.45M Filed 2025-11-26 | $198.91M Filed 2024-11-27 |
| Income tax expense | $52.79M Filed 2026-08-06 | $52.79M Filed 2025-11-26 | $33.11M Filed 2025-11-26 | $36.35M Filed 2025-11-26 | $46.23M Filed 2024-11-27 |
| Net income | $166.31M Filed 2026-08-06 | $162.84M Filed 2025-11-26 | $107.98M Filed 2025-11-26 | $125.64M Filed 2025-11-26 | $152.15M Filed 2024-11-27 |
| Diluted EPS | Unavailable | $2.55 Filed 2025-11-26 | $1.62 Filed 2025-11-26 | $1.88 Filed 2025-11-26 | $2.24 Filed 2024-11-27 |
| Diluted shares | Unavailable | 63.82M Filed 2025-11-26 | 66.86M Filed 2025-11-26 | 66.78M Filed 2025-11-26 | 68.03M Filed 2024-11-27 |
Balance sheet
| Metric | FY 2025 · 2025-09-27 | FY 2025 · 2024-09-28 | 2023-09-30 | 2022-09-24 |
|---|---|---|---|---|
| Cash | $882.49M Filed 2025-11-26 | $753.55M Filed 2025-11-26 | $488.73M Filed 2025-11-26 | $177.44M Filed 2024-11-27 |
| Current assets | $1.98B Filed 2025-11-26 | $1.89B Filed 2025-11-26 | $1.71B Filed 2024-11-27 | $1.55B Filed 2023-11-28 |
| Current liabilities | $538.76M Filed 2025-11-26 | $515.38M Filed 2025-11-26 | $457.99M Filed 2024-11-27 | $465.89M Filed 2023-11-28 |
| Current long-term debt | $62,000 Filed 2025-11-26 | $239,000 Filed 2025-11-26 | $247,000 Filed 2024-11-27 | $317,000 Filed 2023-11-28 |
| Long-term debt, noncurrent | $1.19B Filed 2025-11-26 | $1.19B Filed 2025-11-26 | $1.19B Filed 2024-11-27 | $1.19B Filed 2023-11-28 |
| Total assets | $3.63B Filed 2025-11-26 | $3.55B Filed 2025-11-26 | $3.38B Filed 2025-11-26 | $3.28B Filed 2024-11-27 |
| Stockholders’ equity | $1.58B Filed 2025-11-26 | $1.56B Filed 2025-11-26 | $1.45B Filed 2024-11-27 | $1.33B Filed 2023-11-28 |
Cash flow
| Metric | TTM · 2026-06-27 | FY 2025 · 2025-09-27 | FY 2025 · 2024-09-28 | 2023-09-30 | 2022-09-24 |
|---|---|---|---|---|---|
| Operating cash flow | $390.32M Filed 2026-08-06 | $332.51M Filed 2025-11-26 | $394.89M Filed 2025-11-26 | $381.63M Filed 2025-11-26 | -$34.03M Filed 2024-11-27 |
| Depreciation & amortization | $81.81M Filed 2026-08-06 | $84.89M Filed 2025-11-26 | $90.81M Filed 2025-11-26 | $87.7M Filed 2025-11-26 | $80.95M Filed 2024-11-27 |
| Capital expenditures | $44.69M Filed 2026-08-06 | $41.42M Filed 2025-11-26 | $43.14M Filed 2025-11-26 | $53.97M Filed 2025-11-26 | $115.21M Filed 2024-11-27 |
| Long-term debt issued | Unknown | Unknown | Unknown | $0 Filed 2023-11-28 | $0 Filed 2023-11-28 |
| Long-term debt repaid | $82,000 Filed 2026-08-06 | $231,000 Filed 2025-11-26 | $370,000 Filed 2025-11-26 | $338,000 Filed 2025-11-26 | $1.1M Filed 2024-11-27 |
| Stock repurchases | $29.15M Filed 2026-08-06 | $155.07M Filed 2025-11-26 | $24.08M Filed 2025-11-26 | $37.16M Filed 2025-11-26 | $62.29M Filed 2024-11-27 |
Calculated from the latest TTM financials
Source: SEC filings. Financial facts retain filing dates and are shown only when the retained source and period alignment support them.
Valuation
A supported valuation measure is not available from the current retained price, share-count, and financial inputs.
Statistics
Reproducible trailing, quarterly, and annual statistics from retained SEC financials. Growth and return measures appear only when the required reporting periods align; missing denominators are omitted rather than estimated.
Trailing, quarterly, and annual profitability, return, and growth measures derived from retained SEC financials.
Latest annual liquidity measures using same-period reported current assets and current liabilities.
Trailing cash generation plus latest annual dividends and share repurchases where reported.
Historical financial statistics are descriptive accounting measures, not rankings or investment recommendations.
Ownership
No reviewed company-level insider ownership record is available for this listing.